Moneycontrol PRO

Black Friday Sale

Black Friday Sale

you are here: HomeNewsBusinessCompaniesDrug to treat eye disease won't hit mkt before 2-3 yrs: Biocon

SHOW NAMES

Trending Topics

business

Drug to treat eye disease won't hit mkt before 2-3 yrs: Biocon

Early trials have indicated a positive data for the drug QPI-1007 to treat nonarteritic anterior ischemic optic neuropathy (NAION), says Kiran Mazumdar Shaw, CMD of Boicon.

first published: Jun 23, 2016 09:37 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347